Obesity drug maker Novo Nordisk will spend $6 billion to boost production in Denmark, although its CEO warned the industry was far from being able to meet global demand.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
